as 03-25-2025 3:30pm EST
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
Founded: | 1960 | Country: | United States |
Employees: | N/A | City: | BILLERICA |
Market Cap: | 7.3B | IPO Year: | 2000 |
Target Price: | $68.40 | AVG Volume (30 days): | 2.1M |
Analyst Decision: | Buy | Number of Analysts: | 12 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 0.76 | EPS Growth: | -73.83 |
52 Week Low/High: | $42.70 - $94.64 | Next Earning Date: | 05-01-2025 |
Revenue: | $3,366,400,000 | Revenue Growth: | 13.56% |
Revenue Growth (this year): | 5.81% | Revenue Growth (next year): | 6.23% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Bures Thomas | BRKR | Chief Accounting Officer | Mar 10 '25 | Buy | $47.40 | 500 | $23,697.50 | 3,472 | |
LAUKIEN FRANK H | BRKR | PRESIDENT & CEO | Feb 18 '25 | Buy | $50.99 | 20,000 | $1,018,329.76 | 38,452,626 |
BRKR Breaking Stock News: Dive into BRKR Ticker-Specific Updates for Smart Investing
Insider Monkey
8 days ago
Simply Wall St.
9 days ago
Zacks
13 days ago
StockStory
14 days ago
StockStory
19 days ago
Zacks
20 days ago
Insider Monkey
21 days ago
Argus Research
21 days ago
The information presented on this page, "BRKR Bruker Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.